Search Results 1581-1590 of 38961 for Two-phase

  1. Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. A Study of TAS-120 in Patients with Advanced Solid Tumors - Mayo Clinic

    The purpose of this study is to determine the safety of TAS-120 and determine the most appropriate dose for the subsequent phase 2 safety and efficacy study in ...

  3. Study Evaluating ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    The phase 2 primary objective is to further evaluate the objective response rate (ORR) and very good partial response or better rate (VGPR+) in subjects with t( ...

  4. Migraine Clinical Trials - Mayo Clinic Research

    ... two treatment strategies. Patient Experience with ... phase of the ... phase) and during the migraine attack compared to the between attack phase.

  5. Vaginal tears in childbirth - Mayo Clinic

    Most people have a medical checkup 2 to 3 weeks after a baby is born and ... Stages of labor and birth: Baby, it's time! Tailbone pain · VBAC: Know the ...

  6. Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  7. A Global Phase III Study Of Rilvegostomig Or Pembrolizumab Plus Chemotherapy For First-Line Treatment Of Metastatic Non-squamous NSCLC - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  9. Study Comparing CB-839 with Cabozantinib vs. Cabozantinib with Placebo in Patients with Metastatic Renal Cell Carcinoma - Mayo Clinic

    This study is a randomized Phase 2 evaluation of CB-839 in combination with cabozantinib versus placebo with cabozantinib in patients with advanced or ...

  10. MRI: Is gadolinium safe for people with kidney problems? - Mayo Clinic

    2, 2022. ACR manual on contrast media. American College of Radiology. https://www.acr.org/Clinical-Resources/Contrast-Manual. Accessed Aug. 2, 2022.